RENX — Renalytix Cashflow Statement
0.000.00%
Last trade - 00:00
- £15.76m
- £5.00m
- $3.40m
R2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -7.12 | -10.6 | -35.8 | -49.6 | -46.2 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1.14 | -0.033 | 5.7 | 1.25 | 4.87 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.653 | -0.662 | 3.36 | 0.016 | 6.18 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.2 | -10.1 | -24.6 | -45.7 | -32.7 |
Capital Expenditures | -19.7 | -1.31 | -1.63 | -0.694 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1.99 | 0.827 | 0.889 | — | 0 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -21.7 | -0.485 | -0.741 | -0.694 | 0 |
Financing Cash Flow Items | — | — | 0.111 | -1.51 | -0.16 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 33.1 | 16.5 | 77.2 | 25.5 | 15.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 7.21 | 6 | 51.9 | -23.8 | -16.7 |